Barts and The London School of Medicine and Dentistry

This programme aims to provide students with a clear understanding of the molecular and cellular biology fundamental to cancer biology and cancer research.

Students will learn how research in this area has advanced the treatment and diagnoses of cancer, and gain knowledge of how new therapies are developed, evaluated and implemented.

This will be underpinned by a thorough knowledge of research methodologies and laboratory techniques.

This programme will:

  • Give you a thorough grounding in the principles underlying cancer treatment
  • Introduce you to the regulatory framework underlying clinical research
  • Show you the steps involved in developing and implementing new treatments and how to apply this knowledge in your professional role
  • Encourage you to contribute to the research activity and knowledge base in improving cancer care.

Why study MSc Cancer & Therapeutics at Queen Mary?

Barts and the London School of Medicine and Dentistry is comprised of two world renowned teaching hospitals, St Bartholomew’s and The Royal London, which have made, and continue to make, an outstanding contribution to modern medicine. We were one of the top five in the UK for medicine in the 2008 Research Assessment Exercise. The Barts Cancer Institute (BCI) is a Cancer Research-UK Centre of Excellence and a leading cancer research institute in the UK. The Institute was ranked third in the 2008 Research Review based on the number of international and world-leading cancer researchers.

  • This course provides a solid background to cancer therapy, but then allows you to specialise in areas you are interested in following
  • This course is available via distance learning as well as classroom teaching
  • We have world leading expertise in several cancer therapies and one of the strongest cancer prevention units in Europe
  • This programme provides comprehensive training in research methods
  • Study and contribute to the latest developments in curing cancer, such as novel drugs and gene therapy
  • You will have the opportunity to undertake a three-month dissertation under the supervision of one of our research experts, this may involve setting up a “mock” clinical trial to gain experience of the real world of clinical research and drug development in the cancer setting.

For more information about intercalation please visit the Barts and The London School of Medicine and Dentistry website.

Entry requirements

  • Successfully completed at least 3 years of the MBBS, MbChB or equivalent medical course
  • (for clinically based Masters this must include the equivalent of one year of patient based teaching (in hospital/GP practices/clinics)).
  • Passed year 3 or 4 exams immediately prior to entry at the first opportunity.
  • Demonstrate a clear and unequivocal interest in the field by written application +/- interview.
  • For students internal and external to QMUL it is confirmed that the beginning of the first term for the following year starts after all the QMUL Masters assessments are completed.

Closing date

Monday 4 February 2019